Prelude Capital Management, LLC Sanofi Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$49.47 - $53.77 $1.36 Million - $1.48 Million	-27,586 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$42.91 - $52.5 $1.18 Million - $1.44 Million	27,486 Added 27486.0%	27,586 $1.41 Million
Q1 2020 May 15, 2020	BUY	$38.02 - $51.66 $3,802 - $5,166	100 New	100 $4,000
Q4 2017 Feb 14, 2018	SELL	$42.86 - $50.61 $243,701 - $287,768	-5,686 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$47.04 - $50.34 $267,469 - $286,233	5,686	5,686 $283,000

807

270M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $134B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.